<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Aggressive control of lipids decreases the progression of saphenous vein graft disease</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Aggressive control of lipids decreases the progression of saphenous vein graft disease</h1>
<div class="graphic"><div class="figure"><div class="ttl">Aggressive control of lipids decreases the progression of saphenous vein graft disease</div><div class="cntnt"><img src="data:png;base64,iVBORw0KGgoAAAANSUhEUgAAAYkAAAE/CAMAAACEkM/nAAAACXBIWXMAAAPoAAAD6AG1e1JrAAAAM1BMVEX/AAC8vLxqamooKCh/AAADAwNERET///+AgIB/f3/b19eZmZnz7+//ODj/eXn/s7M/AAD3LfiBAAAOsUlEQVR42uydgWLiIAyGDYyUAuq9/9NeQqvitGo7KnX72c3a2nHKJyQkIew6lG2UHZoAJFBAAiRQQAIkUEACJFBAAiRQQAIkfm0hfy70h0hQ/rCBiJIcE4XrlyOHybPJMt5m+PFtbO5f9/++xvLP/yESzuVGcVKkYch9az3vaPJMb7/bVONt7B7/1z5OXP/ajeXrXH06Hl/+SPvDR5OgZKRZSxJk2ATvomFpV2KOQxMnz3ohsrxqHPvxQvBEsQvyN6kkMV6I+roMO0EryheC16vkaazeeJ/vmSBx2O1eRnE4fjaJLsjTggQ569l756S/BLlupM9oE1vnrRMGxluyzvJ4gaRTcZC/cbYgMV5gl6LTO7tcEXfaBTs5nqu3Pr/op0jIiX7Tj/vD4XA6HA9Bespxvz+kLhz2++P4KCT0JvlN+fzjSHRnEtI+jtjJYB+0UY2eJG1HOQvSDaT3sBwoN914gXRwi/nucCExXpADW5fkFnZe21zodAOJsfqQuU32ieNOOkWSw/6w350OB8Wjz3f7JI+H8bHb7eWlEATdfif3hQ/sE3YkkeX3MMprU3ltqtyw8kzuUJ0mGev0JA9oeiF/n/vh7guJ8c+DMy7KL2USMg7l/2Ykcal+Wk4cdukgw9NeaAiC8aBXtLG1tZVBGh6VhJCTV/P57vAxJLRl2EUZaigPSaMglZZTdXJoqqhf+qHhnNwao4kkjSvXThcyCekfNHSd8+iUL0h/cqoVJKmVicx3EtqnHo1Oabfbyz9t/oFEd0VCR6r8+vAo/7q9lNx3DvOkRlMSbmglZ1Vy6tkoKnr91o9NJUOI40EUB9Zb/aBryfPxwtCKUSRHKCX2cEEB5N+hVv5OQjqgfUTioM0t33w5HjOC8XDUl/bH40F+jiLT82MmcchyRS4dP4bEJkqQXpVFx8R8Qocjbf+0177RjYdMojtoP0j6EIbHTCKpWOmCXgCJOSSy4vV8ji2zChlxTgdYO9oVGXv0Sx+GA0jAAogCEiCBAhIggQIS2yl/1Ge3weK5Hwt7kGhKoj89608ksm83XLl2A0eQeD8J56KaRMouct9zO+HPBYl6JKyag3322orwSIbZXTtujbpzu8KfCxKrkLCO5NdLSxvOLlyjbvfCcdtZbwRX4c8FiVVISBdwXtpeGjupv9zoOFQ6bjUAwrnSnwsS65CQ5s4keDhRr626EX0/Om5p8A6e/Ln9QgUYJJ6S6CgpCVY3YkzOqse1dNz2Jwfs2Z8LEj8u/e18Ygw5EWHMbggicSqxC8dtstkBW/hzQaLiHLvHHPvPFpD4aBKkRQbI6GNCE7YkMUQqyTSGLwEqKG1IaJ/Q0Dx2hDZsSkKtK6ra+WFCSa2M+n+dhE7pNS77O4n3G/WhO+mwFGWiY1w5ofQg8V4SpMZHl4LTBSUBJNqRCNYNYdgyzb+ysYDEVmZ2IAESIAESIAESIAESIAESIAESIAESIAESIPGrSrH+4qYQSLyxXNZf3JSnvhuQqNoA/eRLPUiABEiABEiABEiAxG8gQcunACDxpjnA/PAtkFhnROlBAiRAAiRAAiRAAiRA4kNIRDptlgISbUnobObZ3jIgsT6JnGbdOZBoTiKws8wcQGIbcgISewskgnSJqT3GQOKdJCzkxEZILKYAErW1WAMS2yBhHOTERvoE5MRGSLxYclLhm6xCIFGRRDIcnueeHZIK32QVAom6oxM9tztZN+4ZO2YV+uQMKpvVYiOTf0bCOzPmsbnKZdODRE0SxMT8bGwif00Co9MaWqyz7knq2T4bbPtfklVosxJ7yE/7RHEi40xomFXoJ2t3fpkW2+dtAJplFfrJ2p3PIMHBfIQt9ief+DNI6M7dnzDH/v0kftpAIFFRd5KBP3qQaE0ikTX0dD4BEuuTGGM7ILGbkwjesl+eth0kakYU/GRDdJCoGWUDLXYjJKw6HSAnNkDCkesMSGyChPXQYjcxOhkPLXYr1o64eM9hkKhJgnwMS/UokKjrs3Mn74+bG4UGElXjYolO/WC2vACJmhKb1CM29g+QaDk6sRct1mehzZATDUlwsdJuticVJGpaAPNOmrTMDggSa3lPIzOBxAZIZI2WQKI9ibxROiR2KzlRSAjtD+aXkJiOGuSt6k5c6lH8NEb2U0j4f18T5d9GSVCxNOWVGNmPIfG1myhfWGcHEk/m2KfZnA9Rh9EIEo10p0TyM8jr32Tt+DwSUWYQNvcJSmHubBskqsZ22PM6O+ODswkk2pDQdXanOYSLM5UnkKgaUWD9qfVlnGJfTU60zaT+eSSo8J5adr7eHLttJvUP1J3CVURBsPdGpzCkiZiXLaKtfecDSRSxHV0Io0b7XZgM2u28bBEgMXNmV4xOk7pT1MQdZbYIkFhBdypjOyZ1JzLzcxSAxEzdqYjtmNadosaT3+TteJxBBSTm2p0usR2PdCcZlopsESBRn0QZ2zGlO5H1Ik7mZosAiXkkrmI7JnSnYJ3TUWxetgiQmKnFFuW1/GcgsT6J1/KfgcT6JF7KfwYS65E4h3e8kv8MJFbTnQxd5tgv5D9bk8Sk9bbnv+GfsCfNtW5sx3wSSyJjfhMJZ06yYXa+gtokFrTeb/KeunjSl2avBgaJqp4iG06ygSxINJxjh8uoVDfKBiRm6k6+WGdXdU0RSMwhMezdtU40JkjMITHmPKNidHKcQKIBiWSKmRxr/7DOg8T7STgqSajl25gZNkCQqEeCNQ/gKT5cJtiJuQeJV60wnquRMFf7nuazHn1iTSvMpBYbNF/sKT48eeY4x+bxV0hUfF/T84kfFZBYKTfmEltszTWef5tEmRszrz3180jUXOP5t0mUuTGXrMfe6if+RBKX3JhLchSARLXRqciNuSRvB0hU1J0uuTEX5LIBiWpWcb6HBCTeT6K0bSzxnoJELRLl/tjRzl+PDRLVRqdiZrfEewoSa1g7luTtAIlq1o4cY3cyAc7MzAgS9Vey0MkGNTdbBEhUIxGJ2NgsHZyuHTIg0craoVE2Q5wN7E5NrR1O+sFIwhsiwxRAogWJIW+HiYXMYJBoosUmois9ao4eCxIb8p6CxFtJPMhlAxJvJaECxN7PZQMSdUg4iq84JCgl66jIZXPJFgESlUj4Mt4pPIjaty7czaACEnVIXOutdlqHjde5bDA61SaR4lVc7ORMIhtBilw2IFFfYpexl5PriURQe093c9mARC0Sl7g/Zju1s2AewvzdXDYgUc8qfor7c3NtHSBR3RZrfrDODiSqkSji/nQdKqzirUhc4v6CVz3KgkQra8c57m9ch+pBorXdKZHOtwPkBKziIHHSZ8OSbBEgUZ/Esn2KQKLazM5jPrEFEteaKxsCiUYkrjVXHZ0Ya4raWMWvNdcQGXJiC1psMBYzu2Yk4tX6CUaseDsLYLmmSH0VkBOtSFzN5ALkRDtbbEHCW1gAG87sSjlhZ04oQGKV/bFlbMIcu6UWe94fG9aO5losWQMS7UmU+2ODRFMtttgfGySa9olif2yQaEmi3B8bJJrqTsX+2CDRkoRI63m7CYLEWhI7wnu6Fd3pOtsWSLSbTxBBd4LuBBLQnbbtnwCJtlZxkNiKLXZm7j+QeIPP7kHJMVHI27HqKmB6IUds8BkW8nasugrY8HNrB+duU+TtAIlVRqcX/BMKoeuRt2NduxO/4LPLJG4yqPQgUdlnx6+RQN6OtVcBW/dMiw3RWUrI2/GmvB2PJbYu2kbeDqw9/QMkiBc77ECi6jq7n9jEQaIiiV7zLHqQaE9CZxIMElsgMT+7FkiABLRYkAAJkAAJkAAJkAAJkAAJkAAJkAAJkAAJkAAJkAAJkAAJkAAJkAAJkAAJkAAJkAAJkAAJkAAJkAAJkAAJkAAJkAAJkAAJkFidBHLZbIUEctlshESRy+aUQYU9//uaKP+4nyjyZ/dKv6Suicr6Lb4vqkXiTi4b7v10mXytv/PKRCs8reteZUvrWvl9fVtaWofEqz1wRuX1qtpqXb4aibu5bFZ6m7+xrnok7uayAYkGJO7msgGJFiTe+DZBYqZeS1usaqt1Ea1HAuUHBSRAAqUhiRuT4fIxNtR6T6HWezq/I/pux9ggiRuT4dIP7R3Xek+aXbLGe+pEo88w8l4qftskbtNfL2+9aiQoJVvjPXXB2AwjUBeXvL13krg1VP2Eac2uWmmsk6mufrq46Ov2ThJ+mySiM13FPtF15nnu48Ykbk2GWyBh6oA4y4n83G2bxK3JcLG+o9m0a0lsu0zXufme0bB1h2e/SC95q+50YzL8gb7jKpkd3EJV535FUpN82RyHjZNAAQmQQAEJkEABCZBAAQmQQPlrJIhSl+46hfiRrSgwDzP54HsaPPeBQt5INF3dFm9r65lB4p4Bgbv7e8Q8tABaNxiSjJof+myOUxNwtpEUBMPZ3HSpLbpv0arsQCKTGHbridI68kuemJPXr7I0mDaZnDDJ9RBzoybDJkhrWj+0qg0dxYIEJTNwFQgUlYT8hdQjJAYsgd3/9s5gx2EQBqIyyA41/P/37owNbXrYW7XSqkZVm9LESH5mQmxVNHH0tcUygzUJqhKTLIdhr38fia5dwocRnIO7HvLl8G4znYz+rj5ODi+/tl3RO/Ua/DgsSXBLrJA9bndCy7iidZBY2ilczhSl2GCmfIB2p60patkBSzgYXb6PhEEt7iSE4bs/lpornTbGdrnDXQI+W2xeJDJJGt8PiXaF7oHoAFeznax/8JwJynYxs71WDr2ALMbFsQ35QnVi3fs3Ehejmv9mkEOCrg33JolUIr+rE0sk58x4c+MU40RLEzSFsGcl6kys6z485Kx/LCH/v0hIkoA8vJPowuqf6pQ5Dwn2Mrg3CWfA93EjMWV7/EkC0oMrcENJdQrbIDYjBiZ341XxiXvFHvdqUz5Tdvx3JCKyId/W30nkMgh3WHj/ScKzEnWWQqzZdHlbO/XX7EkSyivCqB0SIEh1WtyM1xEJk4swW0niofqhams92dWTXbUiUSSqFYkiUa1IFIlqRaJIVCsSRaLaX7QfZBkW4jVgkQ0AAAAASUVORK5CYII="/></div><div class="graphic_lgnd">In the Post Coronary Artery Bypass Graft trial of 1353 patients, aggressive treatment of low density lipoprotein (LDL) cholesterol with lovastatin and, if needed, cholestyramine to achieve an LDL &lt;100 mg/dL (2.6 mmol/L) reduced the progression of saphenous vein graft disease, regardless of the number of coronary heart disease (CHD) risk factors. All of the differences were significant except for an almost significant trend in patients with no CHD risk factors (p = 0.07).</div><div class="graphic_reference">Data from Campeau L, Hunninghake DB, Knatterud GL, et al, and Post CABG Trial Investigators. Circulation 1999; 99:3241.</div><div id="graphicVersion">Graphic 72758 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
